ConductScience.org, home

Paper16614742

The natural history of hepatitis C virus (HCV) infection.

Chen SL and 1 other. Int J Med Sci, 2006. Cited by 503 papers, by iCite.

Cite this record

ConductScience Library. The natural history of hepatitis C virus (HCV) infection. Papers, record 16614742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16614742

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The natural history of hepatitis C virus (HCV) infection.
PubMed
Journal
Int J Med Sci
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
503
iCite
Relative citation ratio, by iCite
12.8
iCite
Revised in PubMed
2022-03-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen SLStephen L
2Morgan TRTimothy R

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03090035Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C TreatmentResults

Source ClinicalTrials.gov

Download CSV of trials

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19731576Impact of alcohol on the histological and clinical progression of hepatitis C infection.Hepatology1998https://conductscience.org/library/papers/9731576PubMed
29284263Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission.Pediatr Res1997https://conductscience.org/library/papers/9284263PubMed
310326535Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. International Interferon-alpha Hepatocellular Carcinoma Study Group.Lancet1998https://conductscience.org/library/papers/10326535PubMed
49756471Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.Science1998https://conductscience.org/library/papers/9756471PubMed
52523562Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.Science1989https://conductscience.org/library/papers/2523562PubMed
612407597Alcohol use and hepatitis C.Hepatology2002https://conductscience.org/library/papers/12407597PubMed
714960533Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.Gut2004https://conductscience.org/library/papers/14960533PubMed
87806171Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis.Hepatology1995https://conductscience.org/library/papers/7806171PubMed
912102252Hepatitis C infection in liver transplantation.Am J Transplant2001https://conductscience.org/library/papers/12102252PubMed
1010051497Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.Hepatology1999https://conductscience.org/library/papers/10051497PubMed
1111439948Hepatitis C virus infection.N Engl J Med2001https://conductscience.org/library/papers/11439948PubMed
1210622590Treatment of autoimmune and extrahepatic manifestations of hepatitis C virus infection.J Hepatol1999https://conductscience.org/library/papers/10622590PubMed
131646962A long-term study of hepatitis C virus replication in non-A, non-B hepatitis.N Engl J Med1991https://conductscience.org/library/papers/1646962PubMed
147526215Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.N Engl J Med1994https://conductscience.org/library/papers/7526215PubMed
1515951550Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C.Gut2005https://conductscience.org/library/papers/15951550PubMed
1611732009The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.Hepatology2001https://conductscience.org/library/papers/11732009PubMed
1715560058The epidemiology of acute and chronic hepatitis C.Clin Liver Dis1997https://conductscience.org/library/papers/15560058PubMed
1810498458Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.N Engl J Med1999https://conductscience.org/library/papers/10498458PubMed
197545775Long interval between HCV infection and development of hepatocellular carcinoma.Liver1995https://conductscience.org/library/papers/7545775PubMed
207739682Clinical outcomes after transfusion-associated hepatitis C.N Engl J Med1995https://conductscience.org/library/papers/7739682PubMed

See all 70 referencesDownload CSV of references

Cited by298

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 503 citations.

PMIDTitleJournalYearIn PapersSource
42698754Longitudinal Assessment of Metabolic Syndrome and Direct-Acting Antiviral (DAA) Treatment Adherence in Hepatitis C Patients.Juntendo Med J2026https://conductscience.org/library/papers/42698754PubMed
42344660Comparison of diagnostic performance of transcription-mediated amplification with chemiluminescent microparticle immunoassay in the detection of hepatitis C virus in dialysis patient group.Asian J Transfus Sci2026https://conductscience.org/library/papers/42344660PubMed
42323450Macrophages in oncoviral infections: from immune regulators to therapeutic targets.Inflamm Res2026https://conductscience.org/library/papers/42323450PubMed
42268826Four methods for estimating hepatitis C incidence using extant testing data.PLoS One2026https://conductscience.org/library/papers/42268826PubMed
42104178Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C.Infect Dis Ther2026https://conductscience.org/library/papers/42104178PubMed
42095996Mapping HLA class I and II allele associations with hepatitis C related liver disease progression in an Egyptian cohort.Discov Oncol2026https://conductscience.org/library/papers/42095996PubMed
41754576Recent Progress in Structures and Functions of Hepatitis C Virus NS3/4A Proteins.Viruses2026https://conductscience.org/library/papers/41754576PubMed
41725801The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations.Can Liver J2025https://conductscience.org/library/papers/41725801PubMed
41249934Rapid and simple detection of HCV RNA: enhanced colorimetric RT-LAMP method using unmodified gold nanoparticles.BMC Microbiol2025https://conductscience.org/library/papers/41249934PubMed
40593165Response to therapy with direct antiviral drugs in HCV-infected patients with diabetes.Sci Rep2025https://conductscience.org/library/papers/40593165PubMed
40529596Analytical performance and standardization of four HCV RNA assays in China: an evaluation of sensitivity, precision, and genotype inclusivity.Front Microbiol2025https://conductscience.org/library/papers/40529596PubMed
39839167Outcomes of Low Barrier Hepatitis C Treatment in High Risk Populations From Primary Care.J Community Hosp Intern Med Perspect2024https://conductscience.org/library/papers/39839167PubMed
39611512Role of CALCR expression in liver cancer: Implications for the immunotherapy response.Mol Med Rep2025https://conductscience.org/library/papers/39611512PubMed
39569765Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health Survey.J Viral Hepat2025https://conductscience.org/library/papers/39569765PubMed
39497140Efficacy of 8-week daclatasvir-sofosbuvir regimen in chronic hepatitis C: a systematic review and meta-analysis.Virol J2024https://conductscience.org/library/papers/39497140PubMed
39459866Review of the Effects of Antiviral Therapy on Hepatitis B/C-Related Mortality and the Regression of Fibrosis.Viruses2024https://conductscience.org/library/papers/39459866PubMed
39458102Association between Chronic Hepatitis B/C and Incidence of Osteoporosis and Bone Fractures: Results from a Retrospective Cohort Study.J Clin Med2024https://conductscience.org/library/papers/39458102PubMed
39438719Deep mining reveals the diversity of endogenous viral elements in vertebrate genomes.Nat Microbiol2024https://conductscience.org/library/papers/39438719PubMed
39337105Trends in Hospitalizations of Patients with Hepatitis C Virus in Poland between 2012 and 2022.J Clin Med2024https://conductscience.org/library/papers/39337105PubMed
39283072Comparison of a dual antibody and antigen HCV immunoassay to standard of care algorithmic testing.J Clin Microbiol2024https://conductscience.org/library/papers/39283072PubMed

See all 298 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
RIBAVIRINCHEMBL1643Results1https://conductscience.org/library/drugs/CHEMBL1643

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16614742

GET https://conductscience.org/api/papers/v1/16614742/references?page=2